5:03 PM
Apr 22, 2014
 |  BC Extra  |  Company News

Biocad's rituximab biosimilar approved in Russia

Biocad (St. Petersburg, Russia) said the Russian Ministry of Health approved the company's AcellBia (BCD-20), a biosimilar of autoimmune...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >